Your browser doesn't support javascript.
loading
Developing and validating model systems for immuno-oncology.
McCarthy, Claire E; Zahir, Nastaran; Eljanne, Mariam; Sharon, Elad; Voest, Emile E; Palucka, Karolina.
Afiliação
  • McCarthy CE; Division of Cancer Biology, National Cancer Institute, Rockville, MD, USA.
  • Zahir N; Division of Cancer Biology, National Cancer Institute, Rockville, MD, USA.
  • Eljanne M; Division of Cancer Biology, National Cancer Institute, Rockville, MD, USA.
  • Sharon E; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA.
  • Voest EE; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands. Electronic address: e.voest@nki.nl.
  • Palucka K; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address: karolina.palucka@jax.org.
Cancer Cell ; 39(8): 1018-1022, 2021 08 09.
Article em En | MEDLINE | ID: mdl-34115988
ABSTRACT
Owing to clinical success of immune-checkpoint blockade, immunotherapy is becoming a cornerstone of modern oncology, and immuno-oncology is at the forefront of basic cancer research. This commentary outlines future opportunities for immuno-oncology modeling.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Imunoterapia / Neoplasias / Neoplasias Experimentais Limite: Animals / Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Imunoterapia / Neoplasias / Neoplasias Experimentais Limite: Animals / Humans Idioma: En Revista: Cancer Cell Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos